Imatinib and nilotinib are equally successful in achieving therapy-free remission

Authors

Institutions

Publication Details

Journal
Blood Cancer Journal
Published
2026-03-17
DOI
https://doi.org/10.1038/s41408-026-01462-6
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Imatinib and nilotinib are equally successful in achieving therapy-free remission

Zhenfang Liu, Jian Huang, Huanling Zhu, Yu Zhu et al.
Blood Cancer Journal
Chronic Myeloid Leukemia Treatments
article

Imatinib and nilotinib are equally successful in achieving therapy-free remission

Zhenfang Liu, Jian Huang, Huanling Zhu, Yu Zhu, Fang Cheng, Na Xu, Xin Du, Qian Jiang, Jianyu Weng, Yanli Zhang, Huifang Zhao, Hongbo Ren, Weiming Li, Yu Xin Wang, Yunfan Yang
article en

Abstract

No abstract available for this paper.
Blood Cancer JournalVol. 16(1)
Union Hospital (HK), Peking University (CN), Sichuan University (CN), West China Hospital of Sichuan University (CN), Peking University People's Hospital (CN), First Affiliated Hospital of GuangXi Medical University (CN), Wuhan Union Hospital (CN), Henan Cancer Hospital (CN), Guangdong Academy of Medical Sciences (CN), Dian Diagnostics (China) (CN), Union Hospital (CN), Shenzhen Second People's Hospital (CN), First People's Hospital of Jingzhou (CN), First Affiliated Hospital Zhejiang University (CN), Huazhong University of Science and Technology (CN), Southern Medical University (CN), Nanjing Medical University (CN)
Imperial College London, Huazhong University of Science and Technology, Tongji University, Zhengzhou University, Zhejiang University, Sichuan University, Nanjing Medical University, Peking University, Shenzhen University, Southern Medical University, Nanfang Hospital, Guangxi Medical University, Peking University People's Hospital, Guangdong Provincial People's Hospital, National Key Research and Development Program of China, Tongji Medical College, Huazhong University of Science and Technology, West China Hospital, Sichuan University
Openalex Percentile: Top 20%
Chronic Myeloid Leukemia Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.